Famciclovir and Postherpetic Neuralgia

  1. Stephen Tyring, MD, PhD;
  2. Robin L. Saltzman, MD; and
  3. Robert Dworkin, PhD
  1. University of Texas Medical Branch; Galveston, TX 77555 (Tyring) SmithKline Beecham Pharmaceuticals; Collegeville, PA (Saltzman) University of Rochester School of Medicine and Dentistry; Rochester, NY (Dworkin)

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters. …

    « Previous | Next Article »Table of Contents